Literature DB >> 528627

Cimetidine assay in human plasma by liquid chromatography.

N E Larsen, P Hesselfeldt, S J Rune, E F Hvidberg.   

Abstract

An assay for the determination of cimetidine in human plasma is described. Cimetidine was extracted from alkalized plasma with ethyl acetate, washed once over hydrochloric acid, re-extracted into ethyl acetate, and the organic phase was evaporated to dryness. The residue was dissolved in ethanol and injected into a liquid chromatograph. In vitro sulphoxidation was found to occur in whole blood, for which reason the assay was performed in plasma. The accuracy of the method was found to be within 3% and the lower limit for sensitivity was demonstrated to be 0.1 mg/l using 750 microliters plasma. Five volunteers received 1 g cimetidine perorally per day given in four doses with various intervals. Blood samples were drawn hourly, five dose intervals over two days. The average minimum concentration of plasma cimetidine was found to correlate significantly with the mean value of the area under the time/concentration curve over a period of three dose intervals (r = 0.96).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528627     DOI: 10.1016/s0378-4347(00)81168-8

Source DB:  PubMed          Journal:  J Chromatogr


  9 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  A high-performance liquid chromatographic microassay employing a liquid-solid extraction technique for etintidine in plasma.

Authors:  S M Huang; E Rubin; T B Marriott
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

3.  Time course of phenobarbital and cimetidine mediated changes in hepatic drug metabolism.

Authors:  M Døssing; H Pilsgaard; B Rasmussen; H E Poulsen
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

4.  Development of cimetidine resistance in the Zollinger-Ellison syndrome.

Authors:  B N Andersen; N E Larsen; S J Rune; H Worning
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

5.  Elimination of oral cimetidine in chronic renal failure and during haemodialysis.

Authors:  P A Bjaeldager; J B Jensen; N E Larsen; E F Hvidberg
Journal:  Br J Clin Pharmacol       Date:  1980-06       Impact factor: 4.335

6.  Femoxetine and cimetidine: interaction in healthy volunteers.

Authors:  J Schmidt; A S Sørensen; A Gjerris; O J Rafaelsen; H Mengel
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 7.  Clinical pharmacokinetics of cimetidine.

Authors:  A Somogyi; R Gugler
Journal:  Clin Pharmacokinet       Date:  1983 Nov-Dec       Impact factor: 6.447

8.  Effect of cimetidine on the hepatic extraction of indocyanine green, the portal pressure and the systemic circulation in patients with cirrhosis of the liver.

Authors:  R Herz; M Rössle; T Bonzel; E Keller; W Gerok
Journal:  Klin Wochenschr       Date:  1984-08-16

9.  A radioimmunoassay for the histamine H2-antagonist, tiotidine.

Authors:  P Dobson; T O Yellin
Journal:  Agents Actions       Date:  1984-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.